PRRI

Get our monthly newsletter

Follow us on social media

The UN Convention on Biological Diversity’s (CBD) biosafety negotiations have been the target ofbiotech industry lobbyists and pro-biotech governments from the outset. But some have taken a more subtle approach to their lobbying, hiding their agenda beneath a veneer of public interest. Scrape beneath the surface however and their links to the biotech industry become clear. One such organisation is the Public Research and Regulation Initiative (PRRI) which appeared on the scene after the first biosafety negotiations under the CBD. Apparently independent from industry,this group claims to represent the “public research sector” – but how public is public research when GM is involved? Corporate Europe Observatory exposes PRRI as a corporate driven pro-biotech lobby group on biosafety issues

On the occasion of the International Day of Farmers' Struggle, we have jointly with allies prepared five short visions for a sustainable, healthy and fair food and trade policy to restart this important debate.

Who influences decision-making in the European Union? And how? Welcome to the complex and often shady realm of corporate lobbying, which you can now tour from the comfort of your sofa. Or while queuing for frites. Or even on the go in Brussels, following the virtual route on foot!

Following calls for openness and public participation, the European Commission now advertises its trade negotiations as transparent and inclusive. But crucial information about EU trade deals are still kept from citizens. Even member state governments regularly complain about being left in the dark. At the same time, corporations continue to call the shots on EU trade talks.

One third of the people who occupied top positions in the Directorate‑General for Financial Stability, Financial Services and Capital Markets Union (DG FISMA) during the period 2008-2017 either came from the financial industry or went there after their time at the Commission.